AB InBev 3Q Adj. EBITDA $4.75B; Est. $5.03B

The video discusses the financial performance of Becks Corona in the third quarter, highlighting a miss in EBITDA estimates, weaker sales, and EPS figures. Organic revenue and volume growth also fell short of expectations. Despite these challenges, there is optimism about improving trends in the US and Brazil, though concerns remain about Russia and Europe due to economic factors.

What was the normalized EBITDA for Becks Corona in the third quarter?

• $4.75 billion

• $5.03 billion

• $4.50 billion

• $5.50 billion

How did the company's sales numbers compare to estimates?

• They were significantly higher than estimated

• They were slightly weaker than estimated

• They matched the estimates

• They were higher than estimated

What was the actual organic revenue growth percentage for the third quarter?

• 5.0%

• 4.4%

• 2.3%

• 3.5%

Which region showed an improvement in industry volume trends according to the company?

• Asia

• Russia

• Europe

• United States

What factors contributed to slower growth in Europe?

• High competition

• Bad weather and a slower economy

• Lack of innovation

• Political instability